Cargando…

Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma

Background: Stomach adenocarcinoma (STAD) is a significant global health problem. It is urgent to identify reliable predictors and establish a potential prognostic model. Methods: RNA-sequencing expression data of patients with STAD were downloaded from the Gene Expression Omnibus (GEO) and the Canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tong, Wen, Weiwei, Liu, Hongfei, Zhang, Jun, Zhang, Xiaofeng, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727349/ https://www.ncbi.nlm.nih.gov/pubmed/35004767 http://dx.doi.org/10.3389/fmed.2021.793401

Ejemplares similares

Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma
por: Wang, Qingjun, et al.
Publicado: (2022)

Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma
por: Sun, Dongjie, et al.
Publicado: (2023)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
por: Wang, Xiaohui, et al.
Publicado: (2023)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
por: Han, Chen, et al.
Publicado: (2021)

Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma
por: Wu, Ming, et al.
Publicado: (2020)

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
por: Shao, Changming, et al.
Publicado: (2021)

Development and validation of a novel necroptosis-related gene signature for predicting prognosis and therapeutic response in Ewing sarcoma
por: Zhao, Runhan, et al.
Publicado: (2023)

GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma
por: Ni, Lin, et al.
Publicado: (2023)

Establishment and Validation of a Ferroptosis-Related Long Non-Coding RNA Signature for Predicting the Prognosis of Stomach Adenocarcinoma
por: Zhang, Shuqiong, et al.
Publicado: (2022)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma
por: Huang, Zhihao, et al.
Publicado: (2021)

Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma
por: Ren, Hu, et al.
Publicado: (2020)

Prediction of Mortality Risk After Ischemic Acute Kidney Injury With a Novel Prognostic Model: A Multivariable Prediction Model Development and Validation Study
por: Wang, Mei, et al.
Publicado: (2022)

Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma
por: Yang, Jing, et al.
Publicado: (2023)

An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis
por: Zhou, Kai, et al.
Publicado: (2020)

A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma
por: Khan, Muhammad, et al.
Publicado: (2022)

An Unsupervised Deep Learning-Based Model Using Multiomics Data to Predict Prognosis of Patients with Stomach Adenocarcinoma
por: Chen, Sizhen, et al.
Publicado: (2022)

Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach
por: Lin, Jian-Xian, et al.
Publicado: (2021)

Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Yang, Jinlin, et al.
Publicado: (2014)

Development and Validation of a Prognostic Nomogram for Prognosis in Patients With Renal Artery Stenosis
por: Li, Yan, et al.
Publicado: (2022)

Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Zhang, Yingqing, et al.
Publicado: (2020)

Development a m(6)A regulators characterized by the immune cell infiltration in stomach adenocarcinoma for predicting the prognosis and immunotherapy response
por: Shi, Guodong, et al.
Publicado: (2023)

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

Inferior Vena Cava Tumor Thrombus Secondary to Mucinous Adenocarcinoma of the Stomach
por: Tuck, Nicholas, et al.
Publicado: (2021)

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
por: Li, Zhouhua, et al.
Publicado: (2022)

Development and validation of a prognostic prediction model for iron metabolism-related genes in patients with pancreatic adenocarcinoma
por: Wei, Wenhan, et al.
Publicado: (2023)

A novel microRNA signature predicts survival in stomach adenocarcinoma
por: Ding, Bowen, et al.
Publicado: (2017)

Development and Validation of Nomogram Models for Postoperative Pneumonia in Adult Patients Undergoing Elective Cardiac Surgery
por: Wang, Dashuai, et al.
Publicado: (2021)

Multiple bioinformatics analysis identifies IGFBP1 as associated with the prognosis of stomach adenocarcinoma
por: Luo, Xiao-Ye, et al.
Publicado: (2023)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments
por: Xia, Ruolan, et al.
Publicado: (2021)

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
por: Zhang, Xiu‐Ping, et al.
Publicado: (2021)

A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma
por: Liu, Zining, et al.
Publicado: (2022)

Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study
por: Dai, Zi-Hao, et al.
Publicado: (2020)

Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Poorer prognosis in patients with advanced gastric squamous cell carcinoma compared with adenocarcinoma of the stomach: Case report
por: Meng, Ying, et al.
Publicado: (2017)

Development and validation of outcome prediction models for acute kidney injury patients undergoing continuous renal replacement therapy
por: Li, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c7i3e5kh9m2uqvlu8envr7qo7h